Alkermes advances another addiction drug

More info…
Alkermes Inc. has announced positive results from an early stage clinical trial testing the efficacy of its drug candidate ALKS 33 in treating cocaine addiction, which has attracted a $2.4 million grant from the National Institute on Drug Abuse Grants.

drug addiction help

Speak Your Mind

*